Loading provider…
Loading provider…
Dermatology Physician in Santa Rosa, CA
NPI: 1548255482Primary Practice Location
Redwood Family Dermatology
2725 Mendocino Ave, Santa Rosa, CA
Primary Employer
Redwood Family Dermatology
redwoodfamilydermatology.com
HQ Phone
Get M.D., PH.D. Jeffrey's Phone Numberphone_androidMobile
Get M.D., PH.D. Jeffrey's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1999 - 2027
UT State Medical License
2018 - 2020
WA State Medical License
1996 - 1999

American Board of Dermatology
Dermatology

American Board of Dermatology
Pediatric Dermatology
UC San Diego School of Medicine
medschool.ucsd.edu
Medical School
Until 1996
UCSF School of Medicine
medschool.ucsf.edu
Residency • Dermatology
1999 - 2002
University of Washington
Residency • Pediatrics
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 3,020 | 10,252 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 218 | 309 |
| 3 | 17000Destruction of skin growth | 165 | 203 |
| 4 | 88304Pathology examination of tissue using a microscope, moderately low complexity | 127 | 250 |
| 5 | 17003Destruction of 2-14 skin growths | 125 | 824 |
Somatic Mutations in NEK9 Cause Nevus Comedonicus
Authors: Richard Antaya
Journal: Am J Hum Genet
Lead Sponsor: Verrica Pharmaceuticals Inc.
Collaborators: Instat Consulting, Inc., Paidion Research, Inc., Database Integrations, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: Placebo -Topical Film Forming Solution without VP-102, COMBINATION_PRODUCT: VP-102 - Cantharidin, Topical Film Forming Solution
Lead Sponsor: Redwood Dermatology Sciences
Collaborators: Ultragenyx Pharmaceutical Inc
Intervention / Treatment: BIOLOGICAL: Burosumab
Lead Sponsor: Galderma R&D
Intervention / Treatment: DRUG: Brimonidine